Group testing can improve the cost-efficiency of prospective-retrospective biomarker studies
文献类型：期刊论文
| 作者 | Zhang, Wei1; Zhang, Zhiwei2; Krushkal, Julia2; Liu, Aiyi3 |
| 刊名 | BMC MEDICAL RESEARCH METHODOLOGY
 |
| 出版日期 | 2021-03-19 |
| 卷号 | 21期号:1页码:10 |
| 关键词 | Biomarker study design Cost-efficiency Group testing Pooling Two-phase sampling |
| DOI | 10.1186/s12874-021-01239-4 |
| 英文摘要 | Background Cancer treatment is increasingly dependent on biomarkers for prognostication and treatment selection. Potential biomarkers are frequently evaluated in prospective-retrospective studies in which biomarkers are measured retrospectively on archived specimens after completion of prospective clinical trials. In light of the high costs of some assays, random sampling designs have been proposed that measure biomarkers for a random sub-sample of subjects selected on the basis of observed outcome and possibly other variables. Compared with a standard design that measures biomarkers on all subjects, a random sampling design can be cost-efficient in the sense of reducing the cost of the study substantially while achieving a reasonable level of precision. Methods For a biomarker that indicates the presence of some molecular alteration (e.g., mutation in a gene), we explore the use of a group testing strategy, which involves physically pooling specimens across subjects and assaying pooled samples for the presence of the molecular alteration of interest, for further improvement in cost-efficiency beyond random sampling. We propose simple and general approaches to estimating the prognostic and predictive values of biomarkers with group testing, and conduct simulation studies to validate the proposed estimation procedures and to assess the cost-efficiency of the group testing design in comparison to the standard and random sampling designs. Results Simulation results show that the proposed estimation procedures perform well in realistic settings and that a group testing design can have considerably higher cost-efficiency than a random sampling design. Conclusions Group testing can be used to improve the cost-efficiency of biomarker studies. |
| 资助项目 | National Natural Science Foundation of China[12001522] ; National Institutes of Health (NIH) |
| WOS研究方向 | Health Care Sciences & Services |
| 语种 | 英语 |
| WOS记录号 | WOS:000630733800001 |
| 出版者 | BMC |
| 源URL | [http://ir.amss.ac.cn/handle/2S8OKBNM/58260]  |
| 专题 | 中国科学院数学与系统科学研究院 |
| 通讯作者 | Zhang, Zhiwei |
| 作者单位 | 1.Chinese Acad Sci, Acad Math & Syst Sci, LSC, Beijing, Peoples R China 2.NCI, Biometr Res Program, Div Canc Treatment & Diagnost, NIH, Bethesda, MD 20892 USA 3.Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Biostat & Bioinformat Branch, NIH, Bethesda, MD USA |
| 推荐引用方式 GB/T 7714 | Zhang, Wei,Zhang, Zhiwei,Krushkal, Julia,et al. Group testing can improve the cost-efficiency of prospective-retrospective biomarker studies[J]. BMC MEDICAL RESEARCH METHODOLOGY,2021,21(1):10. |
| APA | Zhang, Wei,Zhang, Zhiwei,Krushkal, Julia,&Liu, Aiyi.(2021).Group testing can improve the cost-efficiency of prospective-retrospective biomarker studies.BMC MEDICAL RESEARCH METHODOLOGY,21(1),10. |
| MLA | Zhang, Wei,et al."Group testing can improve the cost-efficiency of prospective-retrospective biomarker studies".BMC MEDICAL RESEARCH METHODOLOGY 21.1(2021):10. |
入库方式： OAI收割
来源：数学与系统科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。